Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Budgeting is essential for young adults to manage expenses and save for the future. Discover the benefits of budgeting early in life.
26,307 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Two-thirds of the S&P 500 have reported, and the results are surprisingly strong. This could mean smoother gains for ...
Target just raised dividend by a modest 1.8%, marking 55 straight years of increase. This article explains why the mo...
As markets sway, a long-running dividend payer draws retirees seeking steady, rising income. PepsiCo's 50-plus years ...
Maze Therapeutics stock still faces mixed signals from the market: a strong rally after a March dip, paired with a no...
When sandisk stock just dropped, it sent ripples through a volatile memory market. This article breaks down the drive...
A Google-backed study finds only 40% of U.S. workers casually use AI at work, with just 5% AI fluent. The result: big...
When a hedge fund boosts its holdings, investors pay attention. This piece explains why Bridge City nearly tripled it...
Six months into 2026, Ford faces a rare stumble as a Japanese competitor outsells its flagship F-Series in the period...
Discover two AI stocks that Wall Street analysts believe could move significantly higher. Learn what makes them stron...
A hedge fund trend today centers on a lean, two-name portfolio. INDUS Capital Partners boosted its bet on H World Gro...
As Berkshire's new leader, Greg Abel faces a massive cash pile. This article examines why Alphabet is the target, wha...